These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16817339)

  • 1. [Asymptomatic hyperparathyroidism].
    Okazaki T
    Nihon Rinsho; 2006 Jun; Suppl 2():10-5. PubMed ID: 16817339
    [No Abstract]   [Full Text] [Related]  

  • 2. [Present status and problems in vitamin D and sevelamer therapy (discussion)].
    Tahara H; Yumita S; Ishida M; Tsuruta Y; Cunningham J; Fukagawa M; Tominaga Y; Tokumoto M; Onoda N
    Clin Calcium; 2005 Sep; 15 Suppl 1():225-8. PubMed ID: 16279028
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of vitamin D deficiency in continued hyperparathyroidism following parathyroidectomy.
    Redman C; Bodenner D; Stack B
    Head Neck; 2009 Sep; 31(9):1164-7. PubMed ID: 19340862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D deficiency masking primary hyperparathyroidism.
    Hannan FM; Fairney A; Johnston DG
    Ann Clin Biochem; 2004 Sep; 41(Pt 5):405-7. PubMed ID: 15333193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone disease in secondary hyperparathyroidism].
    Hayakawa H; Shigematsu T; Kazama JJ
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():324-9. PubMed ID: 15250317
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin D and common sense.
    Binkley N; Lewiecki EM
    J Clin Densitom; 2011; 14(2):95-9. PubMed ID: 21787515
    [No Abstract]   [Full Text] [Related]  

  • 7. Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism.
    Yamada S; Taniguchi M; Tokumoto M; Tsuruya K; Hirakata H; Iida M
    Ther Apher Dial; 2010 Aug; 14(4):424-31. PubMed ID: 20649764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D deficiency and hyperparathyroidism.
    Richards AJ
    Proc R Soc Med; 1972 Nov; 65(11):1018-9. PubMed ID: 4641997
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperparathyroidism after renal transplantation.
    Alfrey AC; Jenkins D
    N Engl J Med; 1969 Feb; 280(9):507. PubMed ID: 4884337
    [No Abstract]   [Full Text] [Related]  

  • 10. A woman with hypophosphataemia and raised alkaline phosphatase.
    Lam JK; Lam KS; Tan KC; Chow WS; Tso AW; Kung AW
    BMJ; 2010 Jan; 340():b5564. PubMed ID: 20089574
    [No Abstract]   [Full Text] [Related]  

  • 11. An update from the latest workshop on asymptomatic primary hyperparathyroidism.
    Lendel I; Horwith M
    Otolaryngol Clin North Am; 2004 Aug; 37(4):737-49, viii. PubMed ID: 15262512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperparathyroidism: pathophysiology, diagnosis and indications for surgery.
    Boonen S; Bouillon R; Fagard K; Mullens A; Vlayen J; Vanderschueren D
    Acta Otorhinolaryngol Belg; 2001; 55(2):119-27. PubMed ID: 11441470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of osteomalacia due to malabsorption of unusual mechanism in a patient with blind loop syndrome].
    de Sèze S; Bernier JJ; Caroit M; Bordier P; Modigliani R; Rautureau M; Prost A; Houaud JP
    Rev Rhum Mal Osteoartic; 1972 Apr; 39(4):297-303. PubMed ID: 4661685
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of asymptomatic primary hyperparathyroidism. New North American guidelines discussed from a Swedish perspective].
    Nilsson IL; Lundgren E; Ekbom A; Ljunghall S; Rastad J
    Lakartidningen; 2003 Nov; 100(47):3848-50, 3853-4. PubMed ID: 14719237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium receptor/calcium-sensing receptor].
    Nagano N
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):188-90. PubMed ID: 17139821
    [No Abstract]   [Full Text] [Related]  

  • 16. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T; Akizawa T
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up study of biological parameters in elderly institutionalized patients more than one year after discontinuation of calcium-vitamin D supplementation.
    Sebert JL; Fardellone P; Maamer M; Agbomson F; Brazier M; Garabedian M
    Rev Rhum Engl Ed; 1996; 63(7-8):498-501. PubMed ID: 8896064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperparathyroidism].
    Sone T
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():229-32. PubMed ID: 16279637
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
    Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
    Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamin D deficiency in kidney failure. Risk factor for cardiovascular disease].
    Ohman K; Larsson T; Spaak J
    Lakartidningen; 2010 Nov 17-23; 107(46):2884-7. PubMed ID: 21197784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.